Can scientists outsmart evolution by designing drugs atom-by-atom?
In short: As SARS-CoV-2 continues to evolve, the threat of drug-resistant variants looms large. Researchers are now moving beyond traditional methods, exploring everything from tiny sponges to precision-engineered compounds designed at the atomic level to stay one step ahead of the virus's mutations.
The primary challenge in treating COVID-19 is the rapid evolution of the SARS-CoV-2 virus. Public health officials worry that a 'diabolical mutation' could eventually render current treatments ineffective, potentially triggering new waves of severe infection. While Paxlovid remains the most effective oral drug available, researchers have noted that it is relatively easy for the virus to evolve resistance to it. This potential for resistance could lead to significant social disruption. Experts are concerned that such mutations might trigger widespread new outbreaks.
To counter this, a team at Stanford University is working to design antivirals that are more tolerant of mutations. In a study published March 13 in Science Translational Medicine, researchers unveiled a new compound called ML2006a4. This drug works similarly to Paxlovid by binding to coronavirus particles to prevent the virus from replicating, but with a critical difference: it is custom-crafted atom-by-atom to bind more tightly and durably. The study was led by Michael Westberg, who is currently an assistant professor at Aarhus University. Senior author Michael Lin, a professor at Stanford, contributed significantly to this research.
In preclinical experiments, ML2006a4 demonstrated superior performance in preventing deadly infections in mice compared to Paxlovid. Crucially, the compound showed effectiveness against variants that had already developed resistance to Paxlovid. Furthermore, its high potency suggests it might be formulated without the specific component in Paxlovid that causes severe drug interaction concerns. This precision approach aims to provide a more resilient defense against the virus's inevitable evolutionary shifts. This method offers a way to stay ahead of the virus's constant changes. It provides a robust alternative as new waves of infection continue to emerge globally.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Ultra High-Tech Ways Scientists Might Defeat COVID-19
- Also: Drug design at the atomic level to thwart COVID-19
To cite this card, link to https://intellectplus.co.uk/app/science-ultra-high-tech-ways-scientists-might-defeat-covid-19.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Evolutionary biology · More in Science · Latest · A–Z · All topics
